Menlo Park, CA – According to filings with the U.S. Securities and Exchange Commission, Sight Sciences is raising $30,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Paul Badawi played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Sight Sciences

Supported by leading medical technology and private equity investors, Sight Sciences operates two business lines: surgical and non-surgical systems. Its surgical product portfolio consists of the OMNI Surgical System, for use by ophthalmologists. Its non-surgical product portfolio consists of the TearCare System for use by ophthalmologists and optometrists.

To learn more about Sight Sciences, visit http://sightsciences.com/

Contact:
Paul Badawi, Chief Executive Officer
877-266-1144
paul@sightsciences.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved